h1

h2

h3

h4

h5
h6

001     1022756
005     20260130055628.0
024 7 _ |a 2572-9241
|2 ISSN
024 7 _ |a SCOPUS:2-s2.0-105013131363
|2 SCOPUS
024 7 _ |a WOS:001549718800001
|2 WOS
024 7 _ |a 10.1002/hem3.70179
|2 doi
024 7 _ |a pmid:40823315
|2 pmid
024 7 _ |a 10.18154/RWTH-2025-10242
|2 datacite_doi
037 _ _ |a RWTH-2025-10242
041 _ _ |a English
082 _ _ |a 610
100 1 _ |0 P:(DE-82)1026984
|a Gleitz, Hélène F. E.
|b 0
|u rwth
245 _ _ |a Inhibiting the alarmin-driven hematopoiesis-stromal cell crosstalk in primary myelofibrosis ameliorates bone marrow fibrosis
|h online
260 _ _ |a Hoboken
|b John Wiley & Sons Ltd.
|c 2025
300 _ _ |a [1]-15
336 7 _ |0 0
|2 EndNote
|a Journal Article
336 7 _ |0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|a Journal Article
|b journal
|m journal
336 7 _ |2 BibTeX
|a ARTICLE
336 7 _ |2 DRIVER
|a article
336 7 _ |2 DataCite
|a Output Types/Journal article
336 7 _ |2 ORCID
|a JOURNAL_ARTICLE
536 _ _ |0 G:(DE-82)021000-OAPKF
|a OAPKF - Open-Access-Publikation mit Unterstützung der RWTH Aachen University (021000-OAPKF)
|c 021000-OAPKF
|x 0
536 _ _ |0 G:(GEPRIS)514007497
|a DFG project G:(GEPRIS)514007497 - Kartierung der Transkriptions- und Mutationslandschaft des malignen hämatopoetischen Klons in Wechselwirkung mit Fibrose-treibenden Stromazellen in myeloproliferativen Neoplasien (514007497)
|c 514007497
|x 1
536 _ _ |0 G:(GEPRIS)417911533
|a DFG project G:(GEPRIS)417911533 - KFO 344: Mechanismen und molekulare Zielstrukturen der Myelofibrose in Myeloproliferativen Neoplasien (MPN) (417911533)
|c 417911533
|x 2
536 _ _ |0 G:(GEPRIS)504777725
|a DFG project G:(GEPRIS)504777725 - Wechselseitige Interaktion zwischen parodontaler Entzündung und Vorstufen der Leukämie (504777725)
|c 504777725
|x 3
536 _ _ |0 G:(EU-Grant)757339
|a deFIBER - Dissecting the cellular and molecular dynamics of bone marrow fibrosis for improved diagnostics and treatment (757339)
|c 757339
|f ERC-2017-STG
|x 4
536 _ _ |0 G:(EU-Grant)101124542
|a Rewind-MF - Deciphering fibrosis reversal mechanisms in chronic blood cancer for identification of novel predictive and therapeutic strategies (101124542)
|c 101124542
|f ERC-2023-COG
|x 5
536 _ _ |0 G:(EU-Grant)966693
|a de-ALARMIN - Novel Prognostic Personalized Biomarker and Therapeutic Target in Blood Cancer Related Fibrosis (966693)
|c 966693
|f ERC-2020-PoC
|x 6
588 _ _ |a Dataset connected to CrossRef, Journals: publications.rwth-aachen.de
591 _ _ |a Germany
591 _ _ |a Netherlands
700 1 _ |a Fuchs, Stijn N. R.
|b 1
700 1 _ |a Snoeren, Inge A. M.
|b 2
700 1 _ |a Boys, Charlotte
|b 3
700 1 _ |0 P:(DE-82)814331
|a Nagai, James
|b 4
|u rwth
700 1 _ |a Tejeda-Mora, Hector
|b 5
700 1 _ |0 P:(DE-82)1018198
|a Klöker, Vanessa
|b 6
|u rwth
700 1 _ |0 P:(DE-82)943025
|a Pritchard, Jessica E.
|b 7
|u rwth
700 1 _ |a Bakker, Iris J.
|b 8
700 1 _ |a Gargallo Garasa, Marta
|b 9
700 1 _ |a Bindels, Eric
|b 10
700 1 _ |a Saez-Rodriguez, Julio
|b 11
700 1 _ |a Vogl, Thomas
|b 12
700 1 _ |0 P:(DE-588)135824044
|a Kramann, Rafael
|b 13
|u rwth
700 1 _ |a Dugourd, Aurélien
|b 14
700 1 _ |0 P:(DE-82)IDM00542
|a Costa, Ivan G.
|b 15
|u rwth
700 1 _ |0 P:(DE-82)692173
|a Schneider, Rebekka K.
|b 16
|e Corresponding author
|u rwth
773 _ _ |0 PERI:(DE-600)2922183-3
|a 10.1002/hem3.70179
|n 8
|p e70179
|t HemaSphere : open access journal of the European Hematology Association
|v 9
|x 2572-9241
|y 2025
856 4 _ |u https://publications.rwth-aachen.de/record/1022756/files/1022756.pdf
|y OpenAccess
876 7 _ |8 W-2025-01089-b
|9 2025-12-02
|c -390.00
|d 2025-12-02
|e APC
|j DEAL
|l Wiley
|v -27.30
|x 021000-924010
|z Discount
876 7 _ |8 W-2025-01089-b
|9 2025-12-02
|c 100.00
|d 2025-12-02
|e Other
|j DEAL
|l Wiley
|v 7.00
|x 021000-924010
|z Servicepauschale
876 7 _ |8 W-2025-01089-b
|9 2025-12-02
|c 1950.00
|d 2025-12-02
|e APC
|j DEAL
|l Wiley
|v 136.50
|x 021000-924010
909 C O |o oai:publications.rwth-aachen.de:1022756
|p openaire
|p open_access
|p OpenAPC
|p driver
|p VDB
|p ec_fundedresources
|p openCost
|p dnbdelivery
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-82)1026984
|a RWTH Aachen
|b 0
|k RWTH
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-82)814331
|a RWTH Aachen
|b 4
|k RWTH
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-82)1018198
|a RWTH Aachen
|b 6
|k RWTH
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-82)943025
|a RWTH Aachen
|b 7
|k RWTH
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-588)135824044
|a RWTH Aachen
|b 13
|k RWTH
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-82)IDM00542
|a RWTH Aachen
|b 15
|k RWTH
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-82)692173
|a RWTH Aachen
|b 16
|k RWTH
914 1 _ |y 2025
915 1 _ |0 StatID:(DE-HGF)0031
|2 StatID
|a Peer reviewed article
|x 0
915 p c |0 PC:(DE-HGF)0000
|2 APC
|a APC keys set
915 p c |0 PC:(DE-HGF)0001
|2 APC
|a Local Funding
915 p c |0 PC:(DE-HGF)0002
|2 APC
|a DFG OA Publikationskosten
915 p c |0 PC:(DE-HGF)0003
|2 APC
|a DOAJ Journal
915 p c |0 PC:(DE-HGF)0191
|2 APC
|a DEAL: Wiley 01.01.2024
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-18
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b HEMASPHERE : 2022
|d 2024-12-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2024-08-26T06:26:50Z
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2024-08-26T06:26:50Z
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2024-12-18
|w ger
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2024-12-18
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Double anonymous peer review
|d 2024-08-26T06:26:50Z
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2024-12-18
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b HEMASPHERE : 2022
|d 2024-12-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2024-12-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-18
920 1 _ |0 I:(DE-82)811002-2_20140620
|k 811002-2 ; 924010
|l Institut und Lehrstuhl für Zell- und Tumorbiologie
|x 0
920 1 _ |0 I:(DE-82)530000-5_20190109
|k 530000-5 ; 925410
|l Institut und Lehrstuhl für Computergestützte Genomik
|x 1
920 1 _ |0 I:(DE-82)531020-2_20140620
|k 531020-2 ; 932610
|l Klinik und Lehrstuhl für Innere Medizin (mit dem Schwerpunkt Nephrologie und Immunologie)
|x 2
980 _ _ |a APC
980 _ _ |a I:(DE-82)530000-5_20190109
980 _ _ |a I:(DE-82)531020-2_20140620
980 _ _ |a I:(DE-82)811002-2_20140620
980 _ _ |a UNRESTRICTED
980 _ _ |a VDB
980 _ _ |a journal
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21